Trials / Terminated
TerminatedNCT03711318
Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- New York State Psychiatric Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
A short-term treatment with buprenorphine prior to initiating treatment with naltrexone may increase the proportion of heroin-dependent patients successfully inducted onto Vivitrol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine/naloxone | 3 week treatment with buprenorphine/naloxone |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2018-10-18
- Last updated
- 2022-12-22
- Results posted
- 2022-12-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03711318. Inclusion in this directory is not an endorsement.